About the Authors

Girish S Kulkarni

Affiliations Division of Urology, Department of Surgical Oncology, University of Toronto, Toronto, Ontario, Canada , Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

Antonio Finelli

Affiliations Division of Urology, Department of Surgical Oncology, University of Toronto, Toronto, Ontario, Canada , Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

Neil E Fleshner

Affiliation Division of Urology, Department of Surgical Oncology, University of Toronto, Toronto, Ontario, Canada

Michael A. S Jewett

Affiliation Division of Urology, Department of Surgical Oncology, University of Toronto, Toronto, Ontario, Canada

Steven R Lopushinsky

Affiliation Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

Shabbir M. H Alibhai

To whom correspondence should be addressed. E-mail: shabbir.alibhai@uhn.on.ca

Affiliations Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada , Division of General Internal Medicine and Clinical Epidemiology, University of Toronto, Toronto, Ontario, Canada

Competing Interests

MASJ is a consultant to and investigator with Viventia Biotech Inc, Bioniche Inc.

Author Contributions

GSK was responsible for conception and design; acquisition, analysis, and interpretation of data; drafting of manuscript; critical revision of the manuscript for important intellectual content; statistical analyses; securing funding; and approval of final manuscript. AF was responsible for conception and design, acquisition of data, analysis and interpretation of data, drafting of manuscript, critical revision of the manuscript for important intellectual content, statistical analyses, and approval of final manuscript. NEF was responsible for conception and design; analysis and interpretation of data; critical revision of the manuscript for important intellectual content; administrative, technical, and material support; supervision; and approval of final manuscript. MASJ was responsible for analysis and interpretation of data; critical revision of the manuscript for important intellectual content; administrative, technical, and material support; and approval of final manuscript. SRL was responsible for analysis and interpretation of data, drafting of manuscript, critical revision of the manuscript for important intellectual content, and approval of final manuscript. SMHA was responsible for conception and design, analysis and interpretation of data, drafting of manuscript, critical revision of the manuscript for important intellectual content, statistical analyses, supervision, and approval of final manuscript.